{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":16,"n_cols":5,"rows_kept":16,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[10,2,10,3],[11,2,11,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910583021803321"]
[null,null,"Autore",null,"Flaker Greg"]
[null,null,"Titolo",null,"Stroke prevention in atrial fibrillation / / Greg Flaker"]
[null,null,"Pubbl/distr/stampa",null,"St. Louis, Missouri : , : Elsevier, , [2019]"]
[{"$nulls":4},"©2019"]
[null,null,"ISBN",null,"0-323-55430-X"]
[null,null,"Descrizione fisica",null,"1 online resource (203 pages) : illustrations"]
[null,null,"Disciplina",null,"616.8106"]
[null,null,"Soggetti",null,"Cerebrovascular disease - Prevention"]
[{"$nulls":4},"Atrial fibrillation"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"1. An Economic Analysis of Stroke and Atrial Fibrillation / Arnold J. Greenspon, MD -- 2. Pharmacology of Oral Anticoagulants / Paul P. Dobesh, PharmD, FCCP, BCPS and Zachary A. Stacy, PharmD, FCCP, BCPS -- 3. Anticoagulation Drug Trials for Stroke Prevention in Atrial Fibrillation / David A. Manly, MD and Christopher B. Granger, MD -- 4. Risk Stratification in Atrial Fibrillation / Farhan Shahid, MBBS, BSc, Mikhail Dzeshka, MD, Eduard Shantsila, MD, PhD and Gregory Y.H. Lip, MD, FRCP, FACC, FESC -- 5. Subclinical Atrial Fibrillation: Definition, Prevalence, and Treatment Strategies / Abhinav Sharma, MD, FRCPC and Renato D. Lopes, MD, MHS, PhD -- 6. The New Anticoagulation Clinic / Anne E. Rose, PharmD -- 7. Management of Bleeding Associated With Anticoagulation / Geno J. Merli, MD, MACP, FSVM, FHM and Lynda Thomson, PharmD -- 8. Periprocedural Management of Anticoagulation in Patients With Atrial Fibrillation / Richard Weachter, MD and Greg Flaker, MD -- 9. Special Situations: Anticoagulation for Cardioversion / Chad Ward, MD and Michael C. Giudici, MD, FACC, FACP, FHRS -- 10. Anticoagulation for Ablation Procedures / Michael C. Giudici, MD, FACC, FACP, FHRS and Bria Giacomino, DO -- 11. Surgical and Implanted Devices for the Left Atrial Appendage / Sandeep Gautam, MD, MPH and Joshua Payne, MD, MPH -- 12. Patients Taking Oral Anticoagulants for Atrial Fibrillation With Concomitant Complex Disease States / William J. Hucker, MD, PhD, Mitul Kanzaria, MD, and John U. Doherty, MD, FACC -- 13. Stroke and Atrial Fibrillation: The Neurologist's Perspective / Luciana Catanese, MD and Robert G. Hart, MD -- 14. Stroke and Atrial Fibrillation in Chronic Kidney Disease and "]
[{"$nulls":4},"Dialysis / David Collister, MD and Michael Walsh, MD, PhD."]